| UHC Commercial Medical & Drug | Givlaari® (Givosiran) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Lemtrada® (Alemtuzumab) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Niktimvo™ (Axatilimab-Csfr) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Parsabiv® (Etelcalcetide) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Somatostatin Analogs – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-04-01 |
| UHC Commercial Medical & Drug | Tzield® (Teplizumab-Mzwv) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-04-01 |
| Medicare NCD | NCD 20.39 - Cardiac Contractility Modulation (CCM) for Heart Failure (HF) | 2026-04-01 |
| Aetna | Infusion Pumps | 2026-03-31 |
| Aetna | Magnetic Resonance Imaging (MRI) of the Extremities | 2026-03-31 |
| Aetna | Vagus Nerve Stimulation | 2026-03-31 |